Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 18, 2008, Pages 6620-6625

  Purhonen, Susanna ^a   Palm, Jarmo ^a   Rossi, Derrick ^b   Kaskenpää, Nina ^a   Rajantie, Iiro ^a   Ylä Herttuala, Seppo ^c   Alitalo, Kari ^a   Weissman, Irving L ^b   Salven, Petri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Angiogenesis; Cancer; Differentiation; Progenitor; Stem cell

Indexed keywords

ADENOVIRUS VECTOR; POLYPEPTIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; COLLAGEN; LAMININ; MATRIGEL; PROTEOGLYCAN; TIE 1 RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADENOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; MELANOMA; MOUSE; NONHUMAN; PARABIOSIS; PRIORITY JOURNAL; REPORTER GENE; TUMOR GROWTH; VASCULAR ENDOTHELIUM; ANIMAL; ANTIBODY SPECIFICITY; CELL MOTION; CELL PROLIFERATION; CIRCULATION; DRUG COMBINATION; DRUG EFFECT; ENDOTHELIUM CELL; EXPERIMENTAL NEOPLASM; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STEM CELL; VASCULARIZATION;

MUS;

ANIMALS; BLOOD CIRCULATION; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENES, REPORTER; LAMININ; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; PARABIOSIS; PROTEOGLYCANS; RECEPTOR, TIE-1; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 44349143198     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0710516105     Document Type: Article

References (76)

1. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932-936.
2. Asahara T, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
3. Asahara T, et al. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972.
4. Takahashi T, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
5. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77.
6. Ruzinova MB, et al. (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277-289.
7. Bertolini F, Shaked Y, Mancuso P, Kerbel RS (2006) The multifaceted circulating endothelial cell in cancer: Towards marker and target identification. Nat Rev Cancer 6:835-845.
8. Duda DG, Cohen KS, Scadden DT, Jain RK (2007) A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2:805-810.
9. Shaked Y, et al. (2006) Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313:1785-1787.
10. De Palma M, Naldini L (2006) Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta 1766:159-166.
11. Craig N, Li J, Lindahl T, Maynard O, West S (2002) Histology: The lives and deaths of cells in tissues. Molecular Biology of the Cell, eds Albers BJA, Lewis J, Raff M, Roberts KPW (Garland Science, New York and London), p 1280.
12. Folkman J, Kalluri R (2003) Tumor angiogenesis. Cancer Medicine, eds Kufe D, Pollock R, Weichselbaum R, Bast RJ, Gansler T, Holland J, Frei E (BC Decker, Hamilton, Canada), pp 165-166.
13. Lyden D, et al. (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194-1201.
14. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R (2005) Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 102:18111-18116.
15. Nolan DJ, et al. (2007) Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 21:1546-1558.
16. Ciarrocchi A, et al. (2007) Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS ONE 2:e1338.
17. Garcia-Barros M, et al. (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-1159.
18. Hattori K, et al. (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005-1014.
19. Heissig B, et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-637.
20. Aicher A, et al. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9:1370-1376.
21. Bailey AS, et al. (2006) Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA 103:13156-13161.
22. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002) Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826-835.
23. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712.
24. Losordo DW, Dimmeler S (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease: Part II: Cell-based therapies. Circulation 109:2692-2697.
25. Kawamoto A, Losordo DW (2008) Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 18:33-37.
26. De Palma M, Venneri MA, Roca C, Naldini L (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9:789-795.
27. Gothert JR, et al. (2004) Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium. Blood 104:1769-1777.
28. De Palma M, et al. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211-226.
29. Peters BA, et al. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11:261-262.
30. Rajantie I, et al. (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104:2084-2086.
31. Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324.
32. Bunster E, Meyer RK (1933) An improved method of parabiosis. Anat Rec 339:339-343.
33. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL (2001) Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-1936.
34. Vajanto I, et al. (2002) Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med 4:371-380.
35. Hutchins B, et al. (2000) Working toward an adenoviral vector testing standard. Mol Ther 2:532-534.
36. Dion LD, Fang J, Garver RI, Jr (1996) Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. J Virol Methods 56:99-107.
37. Modarai B, Burnand KG, Sawyer B, Smith A (2005) Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation 111:2645-2653.
38. Vasa M, et al. (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103:2885-2890.
39. Iwakura A, et al. (2003) Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108:3115-3121.
40. Urbich C, et al. (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 11:206-213.
41. Gao D, et al. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319:195-198.
42. Bertolini F, et al. (2003) Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 63:4342-4346.
43. Shaked Y, et al. (2005) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7:101-111.
44. Thurston G, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6:460-463.
45. Bailey AS, et al. (2004) Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 103:13-19.
46. Chavakis E, et al. (2005) Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201:63-72.
47. Chang YS, et al. (2000) Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608-14613.
48. Vintersten K, et al. (2004) Mouse in red: Red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40:241-246.
49. Zhang F, et al. (2003) Green fluorescent protein selectively induces HSP70-mediated up-regulation of COX-2 expression in endothelial cells. Blood 102:2115-2121.
50. Shalaby F, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
51. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884-5891.
52. Ziegler BL, et al. (1999) KDR receptor: A key marker defining hematopoietic stem cells. Science 285:1553-1558.
53. Yano M, et al. (1997) Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood 89:4317-4326.
54. Salven P, Hattori K, Heissig B, Rafii S (2002) Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16:1471-1473.
55. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G (2005) PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7:870-879.
56. Grunewald M, et al. (2006) VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 124:175-189.
57. Salven P, Orpana A, Joensuu H (1999) Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 5:487-491.
58. Fazel S, et al. (2006) Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116:1865-1877.
59. Okamoto R, et al. (2005) Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 105:2757-2763.
60. Takakura N, et al. (2000) A role for hematopoietic stem cells in promoting angiogenesis. Cell 102:199-209.
61. Stoll BR, Migliorini C, Kadambi A, Munn LL, Jain RK (2003) A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: Implications for antiangiogenic therapy. Blood 102:2555-2561.
62. Kaplan RN, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827.
63. Clauss M, et al. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629-17634.
64. Udani VM, et al. (2005) Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis. Stem Cells Dev 14:478-486.
65. Rohde E, et al. (2006) Blood monocytes mimic endothelial progenitor cells. Stem Cells 24:357-367.
66. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169.
67. Case J, et al. (2007) Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35:1109-1118.
68. Strauer BE, et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918.
69. Stamm C, et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46.
70. Schachinger V, et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221.
71. Assmus B, et al. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222-1232.
72. Seeger FH, Zeiher AM, Dimmeler S (2007) Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 4(Suppl 1):S110-S113.
73. Anderson DJ, Gage FH, Weissman IL (2001) Can stem cells cross lineage boundaries? Nat Med 7:393-395.
74. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259.
75. Wagers AJ, Weissman IL (2004) Plasticity of adult stem cells. Cell 116:639-648.
76. Balsam LB, et al. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673.